NewAmsterdam Pharma Company NV (NAMS)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-26 | Ms. Louise KooijCAO | -65.00k | 1.67M | Derivative Exercise and Sale | 10.00 - 35.69 | 2.35k | - |
| 2026-05-08 | Bain Capital Life Sciences Investors, LLC法人 | -3.50M | 131.55M | 売り | 37.22 - 39.98 | 2.17M | -61.69% |
| 2026-03-11 | Dr. Louis G. LangeIndependent Non-Executive Director | -44.62k | 1.36M | 売り | 30.41 - 31.23 | 2.32k | -95.06% |
| 2026-03-09 | Dr. Louis G. LangeIndependent Non-Executive Director | 44.62k | 513.12k | Derivative Exercise and Retained Stock | 11.50 | 46.94k | 1,923.23% |
| 2026-03-06 | Dr. Louis G. LangeIndependent Non-Executive Director | -28.19k | 828.95k | 売り | 29.41 | 46.94k | -37.52% |
| 2026-03-05 | Dr. Johannes Jacob Pieter KasteleinFounder, Chief Scientific Officer, Member of Executive Board & Director | -300.00k | 9.09M | Derivative Exercise and Sale | 30.29 - 30.32 | 74.64k | - |
| 2026-03-02 | Dr. Michael Harvey DavidsonCEO, President & Executive Director | -443.71k | 14.75M | Derivative Exercise and Sale | 33.25 | 296.51k | - |
| 2026-02-24 | Dr. Michael Harvey DavidsonCEO, President & Executive Director | -306.29k | 10.58M | Derivative Exercise and Sale | 33.63 - 36.68 | 296.51k | - |
| 2026-02-20 | Dr. Johannes Jacob Pieter KasteleinFounder, Chief Scientific Officer, Member of Executive Board & Director | -45.48k | 1.61M | 売り | 35.00 - 35.46 | 74.64k | -37.86% |
| 2026-01-27 | Ms. Louise KooijCAO | -72.43k | 1.55M | Derivative Exercise and Sale | 10.90 - 32.62 | 2.35k | - |
| 2026-01-23 | Ms. Louise KooijCAO | -72.57k | 1.62M | Derivative Exercise and Sale | 10.90 - 34.37 | 2.35k | - |
| 2026-01-20 | Mr. Mayur Amrat SomaiyaCFO | -100.00k | 2.33M | Derivative Exercise and Sale | 9.26 - 33.80 | 7.55k | - |
| 2026-01-07 | Dr. Michael Harvey DavidsonCEO, President & Executive Director | -11.58k | 0.00 | 売り | - | 296.51k | -3.76% |
| 2026-01-05 | Dr. Johannes Jacob Pieter KasteleinFounder, Chief Scientific Officer, Member of Executive Board & Director | -6.00k | 199.50k | 売り | 33.25 | 120.12k | -4.76% |
| 2026-01-05 | Ms. Louise KooijCAO | -2.65k | 88.01k | 売り | 33.25 | 2.35k | -52.94% |
| 2026-01-05 | Mr. Mayur Amrat SomaiyaCFO | -5.12k | 170.17k | 売り | 33.25 | 7.55k | -40.40% |
| 2025-12-23 | Ms. Louise KooijCAO | -145.00k | 3.74M | Derivative Exercise and Sale | 10.00 - 36.21 | 15.00k | - |
| 2025-02-12 | Bain Capital Life Sciences Investors, LLC法人 | -4.80M | 168.48M | 売り | 35.10 | 297.56k | -94.16% |
| 2025-09-17 | Frazier Life Sciences Management, LP法人 | 21.46k | 508.55k | 買い | 23.70 | 12.90M | 0.17% |
| 2025-09-17 | Frazier Life Sciences Public Overage Fund, L.P.法人 | 4.71k | 111.70k | 買い | 23.70 | 0.00 | -100.00% |
| 2025-11-01 | Frazier Life Sciences Public Overage Fund, L.P.法人 | -2.99M | 0.00 | 売り | - | 0.00 | -100.00% |
| 2025-11-01 | Frazier Life Sciences Management, LP法人 | 2.99M | 0.00 | 買い | - | 12.90M | 30.16% |
| 2025-09-15 | Frazier Life Sciences Management, LP法人 | 660.00 | 15.64k | 買い | 23.70 | 13.65M | 0.00% |
| 2025-09-09 | Ms. Louise KooijCAO | -150.00k | 2.37M | Derivative Exercise and Sale | 10.00 - 26.11 | 15.00k | - |
| 2025-09-08 | Frazier Life Sciences Management, LP法人 | 1.26k | 31.49k | 買い | 24.99 | 13.65M | 0.01% |
| 2025-09-03 | Ms. Louise KooijCAO | -18.07k | 453.45k | 売り | 25.09 | 0.00 | -100.00% |
| 2025-09-02 | Ms. Louise KooijCAO | 18.07k | 0.00 | Derivative Exercise and Retained Stock | - | 33.07k | 120.49% |
| 2025-08-25 | Ms. Louise KooijCAO | -8.27k | 205.57k | 売り | 24.86 | 0.00 | -100.00% |
| 2025-08-21 | Dr. Johannes Jacob Pieter KasteleinFounder, Chief Scientific Officer, Member of Executive Board & Director | -100.00k | 2.47M | 売り | 24.29 - 25.49 | 114.78k | -46.56% |
| 2025-08-11 | Frazier Life Sciences Management, LP法人 | 2.19k | 52.54k | 買い | 23.98 | 59.65k | 3.81% |
| 2025-08-11 | Frazier Life Sciences Management, LP法人 | 471.00 | 11.29k | 買い | 23.98 | 9.85M | 0.00% |
| 2025-08-08 | Forbion Capital Partners B.V.法人 | -53.31k | 1.35M | 売り | 25.00 - 25.28 | 5.93M | -0.89% |
| 2025-07-15 | Mr. Douglas F. KlingCOO | -98.61k | 1.02M | Derivative Exercise and Sale | 10.90 - 22.12 | 0.00 | - |
| 2025-06-24 | Frazier Life Sciences Management, LP法人 | 3.78k | 69.47k | 買い | 18.26 - 18.43 | 9.29M | 0.04% |
| 2025-06-16 | Mr. Douglas F. KlingCOO | -100.00k | 909.43k | Derivative Exercise and Sale | 10.00 - 19.75 | 0.00 | - |
| 2025-06-16 | Frazier Life Sciences Management, LP法人 | 8.58k | 167.38k | 買い | 19.50 | 9.29M | 0.09% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。